Lilly falls on diabetes and animal health concerns

Despite 4Q17 figures that outperformed analyst expectations, Eli Lilly and Co. (NYSE:LLY) fell $4.64 to $81.45 on Wednesday after the pharma

Read the full 215 word article

User Sign In